Dibazol

地巴唑

Report date: 2025/07/16 17:59:38
NME

Base Information

Drug NameDibazol
Drug Alias NameBendazolBendazoli
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsHypertensionSpasmVasospasm, Intracranial +[5] 
Global Approved IndicationsHypertensionSpasmVasospasm, Intracranial +[5] 
Approved Indications in ChinaHypertensionSpasmVasospasm, Intracranial +[5] 
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Lisheng Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertensionSpasmVasospasm, Intracranial +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A